AtaiBeckley develops innovative mental health treatments that address significant unmet medical needs.
AtaiBeckley has raised $149.5M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in October 2025.
AtaiBeckley's investors include Gaingels, Janus Henderson Investors, Catalio Capital Management, Alpha Wave Global, Foresite Capital.
AtaiBeckley is headquartered in Berlin, Germany.
AtaiBeckley develops innovative mental health treatments that address significant unmet medical needs.
AtaiBeckley is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"AtaiBeckley — Funding & Investors." VCBacked, October 16, 2025, https://www.vcbacked.co/company/ataibeckley. Accessed September 18, 2026.
VCBacked. (2025). AtaiBeckley — Funding & Investors. Retrieved September 18, 2026, from https://www.vcbacked.co/company/ataibeckley
{{cite web |title=AtaiBeckley — Funding & Investors |url=https://www.vcbacked.co/company/ataibeckley |website=VCBacked |access-date=September 18, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated